ASCL1 and small cell lung carcinoma: Firstly, the presence of these specific neuroendocrine transcripts, at any stage of disease, was associated with a worse outcome and could be proposed as a noninvasive method to investigate and support the identification of the ASCL1-SCLC subgroup of patients and monitor tumor resistance acquisition during treatments [49].